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Abstract
Purpose: People with spinal cord injury (SCI) experience bone loss and have an elevated rate of fracture
in the paralysed limbs. The literature suggests an exponential time course of bone loss after SCI, but true
rates may vary between patients. We propose systematic evaluation of bone status in the early stages of
SCI to identify fast bone losers.
Method: A case series of six patients with complete SCI were scanned using peripheral Quantitative
Computed Tomography within five weeks and at four, eight and twelve months post-injury. Bone mineral
density (BMD) and content (BMC) were measured at fracture-prone sites in the tibia and femur. Patient-
specific-predictions (PSP) of expected rates of bone loss were produced by individualising published
model equations according to each patient’s measured values at baseline. Wilcoxon Signed-Rank tests
were used to identify changes between time-points; chi-squared tests for differences between measured
and PSP values.
Results: In the lower limbs, mean values decreased significantly between baseline and eight months post-
injury, by 19–31% for trabecular BMD, 21–32% for total BMD, and 9–29% for BMC. Most subjects
showed no significant differences between PSP and measured values, but individuals with significantly
faster rates of bone loss than predicted should be investigated further.
Conclusions: There was considerable intersubject variability in rates of bone loss after SCI. Patients
showing fastest bone loss could benefit from continued follow-up and possibly treatment.
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1 Introduction
One of the consequences of spinal cord injury (SCI) is disuse osteoporosis in the paralysed limbs. The
extent of bone loss following SCI is widely documented [1, 2, 3, 4, 5, 6]. There is also low bone integrity
and an elevated incidence of fractures in SCI, at a rate at least twice that of the general population [7, 8].
The most common fracture locations in SCI are the proximal and distal tibia and the distal femur, with
fewer fractures recorded in the tibial and femoral shafts [9]. At present, there is no consensus on a
systematic approach to the management of sublesional bone loss and fracture after SCI. Spinal injuries
physicians typically have a reactive response to fracture, rather than implementing proactive manage-
ment [10]. Early identification of individuals at highest risk of fracture may allow targeted preventative
treatment, which would ideally begin during their inpatient stay in their primary care or rehabilitation
unit.
Although bone mineral density (BMD) cannot be the sole criterion for assessing fracture risk, it may be
used as an indicator. Based on this principle, Eser et al. [11] have suggested SCI fracture thresholds for
the tibia and femur based on trabecular BMD values derived from peripheral Quantitative Computed
Tomography (pQCT) scans at the distal epiphyses. The pQCT technique has been validated for use in
SCI [12]. Dual-Energy X-ray Absorptiometry (DXA) is the bone densitometry technique currently more
widely used in a clinical setting, but for SCI investigations the benefits of using pQCT over DXA include:
(i) targeted measurements at the sites in the peripheral skeleton most prone to fracture in SCI (distal and
proximal tibia, distal femur) [11, 12]; (ii) true volumetric BMD measurements rather than projected areal
BMD [13, 14]; (iii) the ability to analyse trabecular and cortical bone compartments separately [13, 14, 15].
Cross-sectional studies previously carried out in the chronic SCI population [12, 16] have led to estimates
of the time course of decline in trabecular BMD and other key bone density and geometry parameters
in motor-complete SCI. Although data are also available from longitudinal DXA studies [17, 1], the
measurement artefacts [14] caused by soft-tissue changes that inevitably occur [18] in parallel with loss
of bone mineral in the paralysed limbs, and to varying extents in different subgroups of the population
(e.g. flaccid versus spastic SCI) [16] limit the potential for extrapolation of the results to the wider SCI
population. To date, only a small number of longitudinal studies have been performed in SCI using the
pQCT technique [19, 20], but the measurements were carried out either after the first year of SCI [21] or
with large time intervals between repeat scans [19, 20]. As interventions are likely to be most effective in
the initial stages of SCI, changes within the bones should be determined from as soon as possible after
injury, and followed up at higher temporal resolution to describe the time courses of decline quantitatively
in key bone parameters in the paralysed limbs.
We present longitudinal pQCT data from six patients in the first year of SCI to address two objectives,
which are: (i) to identify the timepoint(s) at which BMD and other bone parameters fall below the normal
range at fracture-prone sites in the absence of any intervention; and (ii) to investigate the potential for
patient-specific predictive modelling of bone loss by adjusting the best-fit equations from the literature
according to each patient’s baseline values obtained from pQCT scans carried out as soon as possible
after SCI.
2 Methods
2.1 Subjects
We recruited inpatients of the Queen Elizabeth National Spinal Injuries Unit with a motor-complete
(grade A or B on the American Spinal Injuries Association Impairment Scale (AIS) [22]) traumatic
SCI at neurological levels C4 and below. Exclusion criteria were: (i) metal implants at scan sites,
(ii) recent fracture in the bone(s) to be scanned, (iii) inability to provide informed consent, (iv) previously
diagnosed metabolic bone disease. The study was approved by the South Glasgow & Clyde Research
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Ethics Committee. All subjects provided their informed consent prior to participation in the study, in
line with the Declaration of Helsinki.
2.2 Procedure
Within 5 weeks of their injury (baseline), subjects underwent peripheral Quantitative Computed Tomog-
raphy (pQCT) scans (XCT 3000, Stratec Medizintechnik, Germany) at the Queen Elizabeth National
Spinal Injuries Unit (Southern General Hospital, Glasgow, UK). Scans were performed unilaterally in the
non-dominant arm and the opposite leg, unless there was recent history of fracture (less than 10 years) in
which case the other limb was scanned. The pQCT scans were repeated at 4, 8 and 12 months post-injury.
Prior to each patient scan, quality assurance scans were performed using the manufacturer’s phantom.
Patients were transferred onto a height-adjustable patient couch. A measuring tape was used to measure
the length of the tibia, from the distal end of the medial malleolus to the medial joint cleft. The femur
length was taken to be equivalent to tibial length for practical reasons. The length of the radius was
measured from the humero-radial joint cleft to the styloid process. The lower-leg was placed through
the gantry, with the foot resting on the footrest. The opposite leg rested on a height-adjustable holder
alongside the scanner. A scout view was performed at the ankle, to enable positioning of the reference
line on the distal endplate of the tibia. The tibia was scanned at 4% of total bone length, starting from
the distal end. The patient was repositioned with the thigh through the gantry. From the distal femur
scout view, the reference line was placed on the lateral femoral condyle; the distal femur was scanned
at 4% from the distal end. From the proximal tibia scout view, the reference line was placed on the
medial aspect of the tibial plateau; the proximal tibia was scanned at 4% from the proximal end. The
patient was repositioned for the upper limb scan. With the hand secured to the handrest, a scoutview
was performed at the wrist to place the reference line on the distal radial endplate. The radius was
scanned at 4% of total bone length, from the distal end. Slice thickness was set at 2mm and voxel size
at 0.5 mm in the tibia and radius and 0.3 mm in the femur. As in the cross-sectional pQCT studies in
SCI by Eser, Frotzler et al. [11, 12, 21], the choice of the smaller voxel size for femoral slices was due to
the typically thin cortical shell at the distal femur epiphysis in this patient group.
2.3 Outcome measures
The manufacturer’s software (XCT550, Stratec Medinzintechnik, Germany) was used for analysis of
the scans. With pQCT absorption values are linearly transformed into hydroxyapatite (HA) equivalent
densities, and HA density measurements are calibrated with respect to fat, set at 0 mg HA cm−3,
and resulting in water being at 60 mg HA cm−3 [23]. At all 4% scan sites (epiphyses), we calculated
trabecular bone mineral density (BMDtrab), total bone mineral density (BMDtot) and bone mineral
content (BMC). A contour algorithm was used with thresholds of 180 mg.cm−3 in the distal tibia, 150
mg.cm−3 in the proximal tibia, 130 mg.cm−3 in the distal femur and 150 mg.cm−3 in the distal radius to
find the periosteal surface of the epiphysis for calculation of BMC, total bone CSA and BMDtrab. For
BMDtrab calculations, concentric pixel layers were automatically peeled off from the perimeter until the
central 45% area remained. Reproducibility of pQCT in SCI is described by Eser et al. based on duplicate
measurements in seven subjects with chronic SCI. This resulted in coefficients of variation ranging from
0.96% (BMC) to 2.04% (BMDtot) in the distal femur epiphysis, and from 0.46% (BMDtot) to 2.23%
(BMDtrab) in the distal tibia epiphysis [12].
2.4 Individualised predictive models
Exponential models previously fitted to cross-sectional data by Eser et al. (2004) [12], to describe the
best-fit pattern of decline in a chronic SCI population, are given for bone parameters of the distal
epiphyses for the tibia and femur in Eq. 1 to 6.
BMDtrabtib = 190.8e
−0.41t + 65.2 (1)
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BMDtrabfem = 139.2e
−0.56t + 112.3 (2)
BMDtottib = 193.6e
−0.47t + 133.2 (3)
BMDtotfem = 128.8e
−0.66t + 144.7 (4)
BMCdistaltib = 2.56e
−0.57t + 1.80 (5)
BMCdistalfem = 5.58e
−0.74t + 5.82 (6)
These model equations were used in combination with pQCT-derived bone parameters measured in our
study at baseline to predict each subject’s individualised pattern of decline, for key bone parameters in
the distal epiphyses of the tibia and femur. The basic model was corrected according to each individual’s
baseline value for each relevant parameter by introducing an additive “shift” term. The assumption
behind this is that the rate of loss is fixed and that the starting value at baseline is the only factor that
alters the actual values at subsequent time points. For each parameter (BMDtrab, BMDtot and BMC) at
the distal epiphyses (tibia, femur), we calculated these predicted values at 4-, 8- and 12-months as follows.
The absolute difference between the actual value at baseline (as determined from pQCT scans) and
the predicted value calculated from the Eser model at baseline provided the shift term to be added for
subsequent time-points (4, 8 and 12 months post-SCI). An example of the computation of this additive
prediction is given in equations 7 and 8, for BMDtrab at the distal tibia.
BMDtrabS = BMDtrabA −BMDtrabM (7)
BMDtrabPa = 190.8e
−0.41t + 65.2 + BMDtrabS (8)
Where t is ‘time’ in years, and:
BMDtrabA = value as measured at baseline, in mg.cm
−3
BMDtrabM = uncorrected model-predicted value at baseline, in mg.cm
−3
BMDtrabS = patient-specific shift term for additive-model prediction, in mg.cm
−3
BMDtrabPa = patient-specific additive model-predicted value at time t, in mg.cm
−3
No models were available for the proximal tibia or distal radius. Predicted values were not calculated for
these sites.
2.5 Statistical methods
Bone parameters were summarised for each time-point (baseline, +4 months, +8 months and +12 months)
by means and standard deviations. Due to the small sample size, Wilcoxon Signed Rank Tests were used
to identify significant differences in key bone parameters in the distal tibia, proximal tibia, distal femur
and distal radius between baseline, 4, 8 and 12 months post-injury. In order to asses how well the baseline
adjusted models predicted values at later time-points, standardised residuals were calculated and summed
for each subject and compared to a chi-squared distribution with three degrees of freedom. Analysis was
carried out in SPSS (version 15.0) and SAS (version 9.1).
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3 Results
3.1 Subjects
Subject details are given in table 1; all had motor-complete traumatic SCI. Subject S2 did not return for
repeat scans at 8 and 12 months post-injury.
Subject SCI level Age Sex
S1 C4 17 M
S2 T9 18 M
S3 C4/5 72 M
S4 T3 17 M
S5 T4 29 M
S6 T6 18 M
Table 1: Subject details. ‘Age’: in years, at the start of participation.
3.2 Measured values — Lower Limb
Each subject’s BMDtrab values as measured at baseline, 4 months post-SCI, 8 months post-SCI and 12
months post-SCI are shown graphically for each subject for the distal tibia, proximal tibia and distal
femur in figure 1. Mean values for BMDtrab, BMDtot and BMC calculated at each time point are
given for the distal and proximal tibia, and the distal femur in table 2. Comparing values between scan
time-points, statistically-significant changes were recorded in trabecular and total BMD, and BMC in
the epiphyses of the bones of the paralysed limbs. At the distal tibia, all changes between the different
scan time-points were statistically significant (with p-values ranging from p=0.028 to p=0.043). At the
proximal tibia there were statistically significant changes between most time-points for all parameters,
except between 8 and 12 months post-injury for BMDtrab and BMDtot (p=0.080). At the distal fe-
mur, there were statistically significant changes between most time-points for most parameters, except
BMDtrab between 4 and 8 months post-injury (p=0.080), BMDtot between 8 and 12 months post-injury
(p=0.080), and BMC between 8 and 12 months post-injury (p=0.080).
The mean values of key bone parameters in the distal epiphyses of the tibia and femur obtained at each
scan time-point can be compared to pQCT reference values from the literature [12] for able-bodied sub-
jects and people with long-term SCI who have reached their steady-state levels. No reference data are
available for the proximal tibia. At the distal epiphyses of the tibia and femur, the group mean fell below
the normal range by 8-months post-injury only. Even at 12-months post-injury, however, these values
remained substantially higher than steady-state values recorded in people with long-term motor-complete
SCI [12, 16]. Although the mean values for bone parameters at the fracture-prone sites at each of the
four time-points post-SCI remain above the mean values reported for long-established SCI, the large
intersubject variability at the 8- and 12-month time-points (as indicated by the SD) shows that some
patients fell to much lower BMD and BMC levels than others in this time frame.
There were some clear differences in patterns of bone loss between subjects and between sites. Subject S4
showed consistently highest percentage loss in the first year of SCI in the tibial epiphyses, ranging from
46% decrease in BMC in the proximal tibia to 67% decrease in BMDtrab in the distal tibia. By 12 months
post-SCI, with a measured BMDtrab value of 87.20 mg.cm−3 at the distal tibia, subject S4 was already
approaching the distal tibia fracture threshold proposed by Eser et al. [11] of around 70 mg.cm−3. In
contrast, the decline in bone values in the distal femur in this subject was less severe, and his final distal
femur BMDtrab at 12 months was only slightly below the normal range at 201.40 mg.cm−3. Subject
S5 showed the largest percentage decreases at the distal femur, and had a more consistent pattern of
bone loss at the three epiphyseal sites investigated in the lower limbs, reaching low values in all the
fracture-prone sites. Subject S5 reached a BMDtrab of 118.80 mg.cm−3 that was close to the distal
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Figure 1: Each subject’s measured trabecular BMD values at at baseline, 4, 8 & 12 months post-SCI.
Bone Parameter Measured values Reference values *
Baseline +4 months +8 months +12 months Chronic SCI Able-bodied
Distal BMDtrab 272.11 256.03 203.43 160.53 66.1 245.8
Tibia [mg.cm−3] (33.62) (39.39) (58.11) (84.18) (23.4) (45.0)
BMDtot 331.75 308.28 254.65 215.40 135.0 312.7
[mg.cm−3] (24.49) (40.16) (46.94) (68.03) (26.9) (49.1)
BMC 4.39 3.96 3.29 2.78 1.80 4.31
[g.cm−2] (0.60) (0.58) (0.67) (0.78) (0.34) (0.64)
Proximal BMDtrab 191.97 171.37 130.77 108.09 no data no data
Tibia [mg.cm−3] (31.57) (33.57) (43.35) (37.73)
BMDtot 250.46 214.98 169.65 151.93 no data no data
[mg.cm−3] (29.13) (26.41) (32.09) (33.32)
BMC 7.57 6.51 5.31 4.78 no data no data
[g.cm−2] (1.16) (1.10) (0.91) (0.78)
Distal BMDtrab 256.99 241.98 207.97 185.91 112.8 243.7
Femur [mg.cm−3] (31.55) (42.62) (47.97) (39.58) (28.3) (30.5)
BMDtot 277.75 253.85 219.50 202.44 146.5 267.6
[mg.cm−3] (23.41) (32.10) (36.12) (27.34) (29.1) (32.9)
BMC 11.41 10.20 8.52 8.02 5.86 11.30
[g.cm−2] (1.23) (1.17) (1.10) (0.95) (1.30) (1.56)
Table 2: Key bone parameters, determined using pQCT, at the distal tibia, proximal tibia and distal
femur; data are shown as mean (SD). (*Taken from Eser et al. 2004 [12]; there are no reference values
for the proximal tibia.)
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femur fracture threshold proposed by Eser et al. [11] of around 110 mg.cm−3, and a distal tibia BMDtrab
of 74.91 mg.cm−3, once again very close to the fracture threshold (70 mg.cm−3). His BMDtrab at the
proximal tibia decreased to 68.41 mg.cm−3, which is also low, but fracture thresholds for this site in SCI
are not available for reference. In contrast, subject S3 showed negligible loss of bone at all measured sites,
ranging from 1% decrease in BMDtrab at the distal femur to 13% decrease in BMDtot at the proximal
tibia.
3.3 Measured values — Upper Limb
Measured values for BMDtrab at the distal radius are shown graphically for all subjects in figure 1.
When comparing key bone parameters at the distal radius at different time-points, only BMDtot differed
significantly between baseline and 4-months post-SCI (p=0.046) and between 8-months and 12-months
post-SCI (p=0.043). Any other differences were not statistically significant. In table 3, mean values
(for paraplegic subjects only) are shown for each time point for BMDtrab, BMDtot and BMC, and are
compared to pQCT reference values from the literature [12] for able-bodied subjects and people with
paraplegia with long-term SCI. For the radius, the mean values for the paraplegic subject group (n=4)
remained above or within the normal range at all four scan time points post-SCI.
Insert table 3 around here.
Parameter Measured values Reference values *
Baseline +4 months +8 months +12 months Chronic SCI Able-bodied
BMDtrab 245.03 239.98 229.94 228.37 202.3 219.7
[mg.cm−3] SD 30.48 (29.03) (16.52) (23.17) (32.5) (46.1)
BMDtot 349.71 331.87 348.41 325.07 352.9 354.0
[mg.cm−3] (22.73) (25.90) (15.24) (28.17) (48.4) (50.8)
BMC 1.55 1.58 1.52 1.59 1.66 1.69
[g.cm−2] (0.18) (0.14) (0.14) (0.08) (0.26) (0.27)
Table 3: Key bone parameters, determined using pQCT, at the distal radius, for paraplegic subjects only
(n=4); data are shown as mean (SD). (* Taken from Eser et al. 2004 [12].)
3.4 Predicted versus Measured Values — Lower Limb
For most subjects, there was no indication that the measured rates of bone loss were slowing during the
last post-injury time window investigated (8–12 months post-SCI) compared to the earlier time windows.
Previous studies have shown that an exponential decay provides the best description of the long-term
relationship between BMD and time since injury. We modified the equations of best fit from the liter-
ature [12] to individualise each patient’s temporal pattern of bone loss according to their own starting
values at baseline. These patient-specific predicted (PSP) patterns of decline in BMDtrab at the epiphy-
ses of the tibia and the femur are shown in relation to their measured patterns of decline, in figure 2. The
results of the analysis of goodness-of-fit between the patient-specific predicted and the measured rates of
decline in BMDtrab, BMDtot and BMC are given for each subject for the distal epiphyses of the tibia
and the femur in table 4.
Subject S4 showed statistically significant deviation from the predicted curve for BMD at the distal tibia
(p=0.010 for BMDtrab; p=0.021 for BMDtot), as confirmed in figure 2, with increasing deviation be-
tween the measured and prediction curves with time post-SCI. Subject S5 showed consistently significant
deviation from the prediction model at the distal femur (p=0.029 for BMDtrab; p=0.050 for BMDtot;
p=0.012 for BMC). In the distal tibia, values for S5 did not differ significantly between predicted and
measured models. For subject S1, predicted and measured BMC values differed significantly, but BMD
measures did not. For all other subjects, no statistically significant differences were detected between the
predicted and measured models.
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Figure 2: Predicted & measured changes in trabecular BMD at distal epiphyses over the first year of SCI.
For each subject, the dashed line represents the patient-specific prediction (PSP) curve and the solid line
follows the measured time course.
Subject Distal Tibia Distal Femur
Chi-square test p-value Chi-square test p-value
BMDtrab BMDtot BMC BMDtrab BMDtot BMC
1 0.339 0.080 0.007* 0.129 0.075 0.288
2 0.752 0.942 0.915 0.619 0.757 0.846
3 0.424 0.377 0.333 0.185 0.209 0.182
4 0.010* 0.021* 0.084 0.823 0.232 0.437
5 0.246 0.436 0.362 0.029* 0.050* 0.012*
6 0.332 0.291 0.890 0.831 0.982 0.909
Table 4: Goodness-of-fit analysis results, comparing the individualised patient-predicted models, and the
measured values at the distal tibia and distal femur. * Statistically significant differences between models
of predicted and measured values (p≤0.05).
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4 Discussion
We characterised bone loss during the first year of SCI through a case series of six SCI patients, enabling
us to investigate the predictive potential of early pQCT bone scans and to identify the first 8 months of
SCI as a key therapeutic window during which early preventative intervention should be implemented in
patients exhibiting high rates of bone loss. In this longitudinal study of six acute patients with motor-
complete SCI, a sequence of pQCT scans was performed within 5 weeks of injury and again at 4-, 8- and
12-months post-SCI, to quantify the changes in key bone parameters in the first year after injury. The
focus here is on the trabecular-rich epiphyses, which typically are the first to show changes in response
to altered loading of the bones [1, 12, 24]. The mean responses of our study group suggest that values of
key bone parameters at fracture-prone sites (distal femur, and proximal and distal tibia) only start to fall
below the normal range at 8 months post-injury. However, the intersubject variability increases at each
successive scan time-point, with some patients showing fast rates of bone loss but others showing little
change in bone parameters over the same time period. Although mean responses are useful in describing
the overall patient population’s bone status relative to normal, detailed investigations of the individual
patients’ own rates and magnitudes of bone loss are likely to be more informative in a proactive approach
to management of sublesional bone loss in SCI, to enable clinicians to target treatments towards those
patients showing the most extensive and/or rapid bone loss. There was large intersubject variability in
the rates of bone loss in the paralysed limbs in the first year of SCI, but less intrasubject variability: those
patients showing bone loss tended to have similar rates of decline in BMD and BMC at all fracture-prone
sites. Based on our initial findings, we propose a densitometric method of screening SCI patients in the
first few months of their injury to identify those with high rates of bone loss at fracture-prone sites early
on.
We produced patient-specific-predictions (PSP) of the time course of bone loss at the distal epiphyses
of the tibia and femur. The underlying assumptions of these individualised models were that: (i) all
patients experience the same rate of bone loss (described by an exponential decay equation); and (ii) any
differences in bone values between patients at any particular time point are explained by differences in
their starting values at baseline, i.e. their initial bone status. We compared PSP curves with the actual
measured values at those time-points to determine the validity of these assumptions. A goodness-of-fit
(chi-squared test) analysis showed that, for most patients, there were no statistically significant differences
between predicted values and measured values of BMC, BMDtrab and BMDtot at the distal epiphyses of
the tibia and femur. For BMD values, the exceptions were subjects S4 (for the distal tibia) and S5 (for the
distal femur), whose deviations from the PSP curves became greater with time post-injury. This analysis
showed them to be losing bone in the first 12 months at faster rates and more extensively than predicted.
To achieve fracture-risk diagnosis based on pQCT densitometry, these statistically significant deviations
could be used as a “red flag”. For example, for the two patients showing much lower BMD values than
expected at one year post-SCI, one could postulate an increased fracture risk, as they both approached
the BMDtrab-based fracture thresholds proposed by Eseret al. [11] of 70 mg.cm−3 for the distal tibia and
110 mg.cm−3 for the distal femur by the end of the period of investigation. Thus, there may be potential
for implementing patient-specific predictions of bone loss at key sites in the paralysed limbs to identify
individuals at highest risk of fracture. However, it is clear that there are other factors that may need to
be considered when analysing fracture risk. Additional fracture risk factors are not explored in this paper.
Some (potentially significant) amount of bone loss may have occurred prior to the baseline scans. Ide-
ally, the baseline scans would be carried out within days of injury, but the earliest that we were able
to perform them was 3 weeks post-SCI due to the acute effects of SCI on the patients. On average,
baseline scans were performed at 4.2 SD 0.6 weeks post-injury. The extent of any bone loss prior to
this is unknown. We can only base patient-specific predictions on the earliest timepoint at which we can
achieve the bone imaging safely, once the patient is neurologically stable. By applying the model to the
time period preceding the baseline scan, we can then infer by interpolation the starting BMD and other
bone values at the time of injury. A factor that could contribute to differential rates of bone loss in the
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first few weeks post-SCI is the length of the “spinal shock” phase. Others may be the length of time
on bedrest and immobilisation. From bedrest studies [25], used to simulate conditions experienced by
astronauts in space flight, immobilisation-related bone resorption has been shown to occur as early as
day 7 of bed rest, and to peak at around 92–102 days of bed rest. After SCI, as the length of time of
spinal shock, immobilisation and bedrest varies from patient to patient, this may also explain some of the
intersubject variability in bone parameters at baseline and 4 months post-injury. However, postulating
an effect of the length of spinal shock and immobilisation periods on the rate of bone loss during the
acute stages of SCI would be speculative at this stage.
We suggest that some patients follow a close-to-predicted pattern of bone loss whilst others deviate
substantially from it. This provides some support for the hypothesis proposed by other authors [26, 3]
that persons with osteoporosis can be classed into “fast” and “slow” bone losers. Dambacher et al. [26]
proposed this distinction for postmenopausal women with osteoporosis, and identified trabecular BMD
as an appropriate parameter to distinguish between the two subgroups. deBruin et al. [3] suggested an
equivalent pattern in patients with disuse osteoporosis as a result of SCI, based on their results from a
longitudinal pQCT study in ten SCI patients involving an initial scan in the acute phase and a repeat
scan at around 3 years post-injury. From these data, the investigators observed that some subjects lost
much less bone than others over the investigation period. These “slow” bone losers showed no sign of
reaching a steady-state, continuing to lose bone at a slow rate. In contrast, other subjects showed a much
higher rate of decline in bone density over the same period. Based on only six subjects in our study,
it is not possible to identify a single source of any apparent difference between “fast” and “slow” bone
losers, but this warrants further investigation. Regardless of the possible cause(s) of these differences, if a
clear bimodality in bone responses to SCI could be determined by continuing to collect longitudinal data
from additional acute SCI subjects, we may be able to produce separate predictive equations for these
two subgroups. If we do not make the distinction, the basic model (or mean response) fitted to data
from a mixed cross-section of the chronic SCI population would underestimate the rate and magnitude
of bone loss in “fast” losers and overestimate the bone loss in “slow” bone losers, and would reduce
the applicability and validity of the predictive equations. In an extension to the study, we propose that
patients should be followed up until they show a plateau in their bone values — chronic steady-state
values. Based on the literature, this is expected to occur at 3–7 years post-SCI [12], but we would see this
occurring earlier in some subjects (“fast” bone losers) and later in others (“slow” bone losers) if there is
indeed a distinction in rates of bone loss between them.
The focus of this paper is on changes in bone at fracture-prone sites in SCI, and so PSPs were only
determined for these. However, we also carried out pQCT scans at the distal radius. Fragility fractures
of the radius are not common in SCI, and we expect no or minimal bone loss in the non-paralysed upper
limbs of paraplegic subjects. This was confirmed with paraplegic subjects showing little change in the
radius, remaining in the normal range over the 12-month period. In tetraplegic patients, epiphyseal data
from the distal radius allowed us to investigate whether or not bone loss occurs in the radius to a similar
extent as in the tibia and femur in subjects with cervical level SCI. Some bone loss would be expected in
the radius in tetraplegia, where there is paralysis of upper limb muscles as well as the lower limb ones,
albeit to varying extents depending on the exact level of injury. Both subjects with tetraplegia included
in this study had motor-complete high-level cervical injuries, resulting in paralysis of elbow, wrist and
finger flexors and extensors. One subject with tetraplegia (S1) showed clear bone loss in the radius, as
well as in the tibia and femur, whereas the other (S3) showed only minimal changes at all scan sites. This
might suggest that at least in high tetraplegia those who experience bone loss in the lower extremities
also experience bone loss in the upper extremities.
The elderly subject (S3) with complete tetraplegia showed much less decline in bone parameters than
expected at all scan sites. Comparing this response with the extensive bone loss in a teenager (S1) with
complete tetraplegia who showed extensive bone loss in the paralysed limbs, we might be led to speculate
that age may play a role in determining rates of bone loss after SCI. (Age-related differences in bone
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density and geometry have been documented for the young [27, 28] and the elderly [29] in the general
population.) However, larger numbers of patients would need to be included in the study to ascertain
possible effects of age on the bones’ responses to SCI.
By starting the longitudinal investigation as soon as possible after the injury, we were able to develop
uniquely accurate and detailed documentation of the rates and extents of bone loss in a in a case series
of six patients with SCI, and to investigate the potential for individualised predictive modelling for this
patient group. These data would allow us to propose a practical tool that could be implemented as part
of a management plan in SCI, and to inform future interventional study design. Possible interventions
may be pharmacological agents or bone-strengthening rehabilitation programmes (or a combination of
the two), but there is currently no single treatment that has been shown conclusively to attenuate or
reverse bone loss in SCI. Interventions aimed at retarding bone loss in these early stages of SCI are
expected to yield greater success rates than those introduced at a later stage and aimed at reversing bone
loss once it is already established, in chronic SCI [21, 5].
In a clinical implementation of these findings, we would propose that patients are scanned using pQCT
as soon as possible after SCI (e.g. within 5 weeks) and predictions made as to the individuals’ expected
rates of bone loss, to identify the time point at which they would be expected to start to fall below the
normal range. Ideally, repeat scans would be performed at around eight months post-SCI, as this is the
time-point at which statistically significant changes were first identified in our study. For each patient,
clinicians could determine whether or not the rate of bone loss within the first eight months deviates
significantly from the predicted rate, and whether values at that time-point have already fallen below
the normal range. This could inform the clinical decision of whether to manage those patients through
education on bone loss and fracture risk in SCI alone, to initiate treatment against further bone loss, or
a combination of the two. Follow-up scans thereafter would determine the effectiveness of any chosen
intervention. We will be able to extend the clinical application after collecting data to represent other
subgroups of the SCI population, including women (pre- and post-menopausal separately) and motor-
incomplete SCI. Increasing the numbers of patients investigated within each subgroup would also enable
us to determine any effect of age on the response of the musculoskeletal system to SCI. This longer-term
study is underway. With larger numbers, we plan to prepare nomograms (similar to those currently
available for DXA, with T- and Z-scores) to provide an easy-reference tool for SCI physicians.
There are a number of limitations to this study. Although we focus on bone parameters in the epiphyses
of the bones in this paper, a longer period of investigation of changes in bone parameters in the shaft of
the tibia, femur and radius would provide additional key information about any differences in the rates
of bone loss at different sites along the bone (i.e. the spatial distribution of bone loss) and the effects of
differential bone loss along the bone on the bone’s geometry and strength. This would provide a more
complete pQCT-based evaluation of fracture risk in this patient population. By extending the period
of investigation through regular repeat scans until each subject’s BMD values level off to a new, lower
“steady-state” would be the way to confirm the validity of our individualised predictions of patterns
of bone loss. A second issue is that the question of whether differences in measured rates of bone loss
are real or not depends on the repeatability and reliability of the pQCT scans. We do not present
repeatability or reliability in this paper, as these have been cited elsewhere in the validation of use of
pQCT in SCI [12]. There are issues of repositioning to obtain the same orientation of the bone during
repeat scans, which are often more pronounced for the proximal tibia and distal femur than for the distal
tibia. This is likely due to the different shapes of the condyles of the bones at each site, and the ease
of patient limb positioning at different times post-injury, depending on the differences in spasticity, tone
or increased/decreased fat and muscle atrophy in the paralysed limbs over time. Bone densitometry is
not the only tool for predicting bone loss in SCI. Blood and urine samples could be collected at regular
intervals post-injury for analysis of biochemical markers of bone resorption and formation. These data
may complement BMD and other bone architecture measurements, and may even enable characterisation
of rates of bone loss at earlier timepoints post-injury than bone densitometry. Analysis of biochemical
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markers of turnover, and the investigation of clinical factors alongside bone densitometric evaluations
would produce a more complete description of bone loss after SCI. The applicability of this work may,
in time, extend to other patient groups that exhibit high rates of bone loss following trauma or disease,
including stroke and multiple sclerosis. Further work would be needed to validate the nomograms that
will result from this ongoing longitudinal SCI study, for use in these other patient groups.
5 Conclusions
In this longitudinal study of six acute patients with motor-complete SCI (4 paraplegia, 2 tetraplegia),
we used a sequence of pQCT scans performed within 5 weeks of injury and again at 4-, 8-months and
12-months post-SCI, to quantify the decline in key bone parameters in the early phases of injury. The
temporal and spatial pattern of bone loss shown during the first year of SCI varied between subjects,
with some showing consistent loss at all measured epiphyseal sites in the paralysed limbs, others showing
more loss at some sites compared to others, and yet others showing minimal loss at all sites. This makes a
strong case for implementing a clinical tool that would enable clinicians to identify those patients (during
their stay in the spinal unit) who are showing rapid and extensive loss of bone during the initial phases
of SCI, and target them for treatment and follow-up. We propose that one method to achieve this would
be to use patient-specific predictions of bone loss based on an initial pQCT scan performed as soon as
possible after injury. Results from repeat scans at eight-months post-injury could then be compared to
predicted values, and used in parallel with reference values for the general population and proposed BMD
fracture thresholds at fracture-prone sites, to flag up those high-risk patients. The first 8-months after
SCI may prove to be the key therapeutic window during which early intervention should be implemented
in this patient group. A longer-term study, characterising the bone loss in larger numbers of SCI patients
should confirm this, and enable us to produce nomograms for the SCI physicians as a reference guide to
assist in decision-making regarding therapeutic intervention.
6 Implications for Rehabilitation
• Spinal cord injury (SCI) leads to extensive muscle paralysis, and is often accompanied by significant
bone loss and increased fracture risk.
• Repeat bone scans within months of injury can be used to “red-flag” patients who are losing bone
faster than predicted.
• A patient-specific approach to osteoporosis management will facilitate targeted treatment aimed at
those who need it most, in SCI and other patient groups.
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